StockData
LB Pharmaceuticals Inc logo

LB Pharmaceuticals Inc (LBRX) stock

LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$40.30−2.69 (-6.26%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

LB Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

LB Pharmaceuticals's cash was $324.90M at Jun 30, 2026. For fiscal 2025 it was $295.20M, up 1060.2% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$295.20M+1060.2%
FY2024Dec 31, 2024$25.45M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$324.90M+1176.9%
Q1 FY2026Mar 31, 2026$364.85M–
Q4 FY2025Dec 31, 2025$295.20M–
Q3 FY2025Sep 30, 2025$314.50M–
Q4 FY2024Dec 31, 2024$25.45M–

More LB Pharmaceuticals figures

See a number that looks wrong?